Durable Responses and Survival in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients Receiving the Allogeneic Leukemia-derived Dendritic Cell Vaccine DCP-001

LLG Janssen, TM Westers, J Rovers, PJM Valk, J Cloos, TD de Gruijl, AA van de Loosdrecht

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

69 Downloads (Pure)
Original languageEnglish
Pages (from-to)E968
JournalHemaSphere
Volume7
Issue number11
DOIs
Publication statusPublished - 2 Nov 2023

Bibliographical note

Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.

Cite this